News Conference News ESC 2017 COMPASS Charts New Course for Rivaroxaban in Stable Vascular Disease Todd Neale August 27, 2017
News Daily News Evolocumab Not Cost-Effective at Current List Price Michael O'Riordan August 23, 2017
News Opinion Editor's Corner ESC 2017 ESC 2017: In Tragedy’s Wake, Cardiology’s Biggest Congress Forges On Shelley Wood August 18, 2017
News Features A Heart to Hold: 3-D Printers Add New Dimension to the Treatment of Structural Cardiac Disease Yael L. Maxwell August 02, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for July 2017 Shelley Wood July 31, 2017
News Daily News No Downside to Medicare Penalties for Hospital Readmissions for HF, Acute MI Ashley Lyles July 18, 2017
News Conference News SCCT 2017 Coronary Calcium Scores in 2017: Useful, Yes, but Hard Outcomes Data Still Lacking Yael L. Maxwell July 13, 2017
News Daily News Identifying CAD in Stable Patients: CT Imaging or Start With Functional Testing? Yael L. Maxwell July 12, 2017
News Conference News SCCT 2017 Nonobstructive Coronary Disease on Cardiac CT: Call to Action, or Wait and See? Yael L. Maxwell July 10, 2017
News Conference News SCCT 2017 Faster, On-site FFRCT May Be on the Horizon Through Innovation and Collaboration Yael L. Maxwell July 09, 2017
News Daily News Real-World TEVAR Population Shows Female Sex Independently Predictive of Mortality L.A. McKeown July 04, 2017
News Daily News Top-Line REVEAL Results Support Efficacy of CETP Inhibition, but Questions Abound Todd Neale June 27, 2017
News Daily News Smartphone App Mobilizes Members of the Public to Be Cardiac Arrest First Responders Todd Neale June 21, 2017
News Daily News Optimal Cardiovascular Health Not Offset by Poor Health as a Whole Ashley Lyles June 20, 2017
News Conference News TVT 2017 Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10 Shelley Wood June 12, 2017
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for May 2017 Shelley Wood June 01, 2017
News Conference News EuroPCR 2017 DESSOLVE III: MiStent Holds Up Well Against Xience at 12 Months, Hints at Potential Longer-Term Benefit Michael O'Riordan May 16, 2017
News Daily News HF Survival Rates Worse Than Those of Common Cancers, Including Bladder and Breast Cancer Michael O'Riordan May 10, 2017
News Features Stents as Essential Medicine: India’s Cap on Stent Prices Could Have Ripples Around the Globe Shelley Wood May 05, 2017